THE THOUSAND FACES OF COUGH: CLINICAL AND THERAPEUTIC UPDATES: REAL
DIAGNOSTIC AND THERAPEUTIC VALUE OF PPIS. F. Baldi, Zanasi et al.
Multidisciplinary Respiratory Medicine (2018) 13:17
TOPICAL PROTECTION OF ESOPHAGEAL MUCOSA:IN VITRO EVALUATION OF A MEDICAL DEVICE MADE
OF NATURAL SUBSTANCES IN COMPARISON WITH SODIUM ALGINATE. G. Liguori, F. Baldi, M. Di Simone
Gastroenterology 2018; 154 (6), S696
PPI-REFRACTORY GERD: AN INTRIGUING, PROBABLY OVERESTIMATED,
PHENOMENON. F. Baldi Curr Gastroenterol Rep 2015; 17:25
EFFECTIVENESS OF ANTIREFLUX SURGERY FOR THE CURE OF CHRONIC COUGH
ASSOCIATED WITH GASTROESOPHAGEAL REFLUX DISEASE. M. Lugaresi, B. Aramini,
N.Daddi, F. Baldi, S. Mattioli. World J Surg. 2015 Jan;39(1):208-15
GASTROESOPHAGEAL REFLUX AND CHRONIC UNEXPLAINED COUGH: PRELIMINARY
RESULTS OF A GISMAD MULTICENTER STUDY. R. Solimando, F. Baldi, G. Cataudella, M. Cicala et al.
Digestive and Liver Disease 2013; 45:S 111
BARRIER EFFECT OF ESSOX ON ESOPHAGEAL MUCOSAL DAMAGE: experimental study on
ex-vivo swine model. M.P.Di Simone, F.Baldi, V.Vasina, F.Scorrano, M.L.Bacci, A.Ferrieri,
G.Poggioli. Clinical and Experimental Gastroenterology 2012:5 1–5
FOCUS ON ACUTE DIARRHOEAL DISEASE. F. Baldi, MA Bianco, G. Nardone, A. Pilotto,
E.Zamparo. World J Gastroenterol 2009;15:3341-8. PMID 19610134
BODY WEIGHT, LIFESTYLE, DIETARY HABITS AND GASTROESOPHAGEAL REFLUX
DISEASE. D. Festi, E. Scapoli, F. Baldi, A. Vestito, F. Pasqui, AR Di Biase, A. Colecchia.
World J Gastroenterol 2009;15:1690-701. PMID 19360912
REFLUX OESOPHAGITIS IN ITALY (Diomede project)
F.Baldi, ,C.Cavoli , M.A.Bianco ,L. Cipolletta, G. Costamagna, S.Passaretti, R. Solimando
Digestive and Liver Disease 2008; 40(6):405-411
KEY POINTS IN THE MANAGEMENT OF GASTROESOPHAGEAL REFLUX DISEASE.
F. Baldi , Curr Gastroenterol Rep 2007;9:1-2.
COST-EFFECTIVENESS OF DIFFERENT DIAGNOSTIC STRATEGIES TO ASSESS GASTRO-
OESOPHAGEAL REFLUX DISEASE IN PATIENTS WITH UNEXPLAINED CHRONIC
PERSISTENT COUGH IN ITALY. F.Baldi, C.Cavoli, S.Ghersi,L.Mantovani,F.Torresan,E.Roda
Digestive and Liver Disease 2006; 38: 452-458.
PROTON PUMP INHIBITOR TREATMENT OF PATIENTS WITH GASTROESOPHAGEAL
REFLUX-RELATED CHRONIC COUGH: A COMPARISON BETWEEN TWO DIFFERENT
DAILY DOSES OF LANSOPRAZOLE. F.Baldi, R. cappiello, C. cavoli, S. Ghersi, F. Torresan, E. Roda ,
World J Gastroenterol 2006; 12: 83-89.
ARTIFICIAL NEURAL NETWORKS ARE ABLE TO RECOGNIZE GASTRO-OESOPHAGEAL
REFLUX DISEASE PATIENTS SOLELY ON THE BASIS OF CLINICAL DATA.
F. Pace, M. Buscema, P. Dominaci, M. Intraligi, F. Baldi, R. Cestari, S. Passaretti, G. Bianchi Porro,
E. Grossi. , Eur J Gastroenterol Hepatol 2005; 17: 605-610.
